Рынок липидов POCT на Ближнем Востоке и в Африке – тенденции отрасли и прогноз до 2028 года

Настройте свой отчет Настройте свой отчет Купить сейчас Купить сейчас Бесплатный пример отчета Бесплатный пример отчета
Дом Healthcare Middle East And Africa Lipid Poct Market
Запрос на TOC Запрос на TOC Обратиться к аналитику Обратиться к аналитику Купить сейчас Купить сейчас Узнать перед покупкой Узнать перед покупкой Бесплатный пример отчета Бесплатный пример отчета

Рынок липидов POCT на Ближнем Востоке и в Африке – тенденции отрасли и прогноз до 2028 года

  • Healthcare
  • Published Report
  • May 2021
  • MEA
  • 350 Pages
  • Количество таблиц: 119
  • Количество рисунков: 34
Купить сейчасКупить сейчас

Рынок липидов POCT на Ближнем Востоке и в Африке по типу (инструменты, расходные материалы и наборы), применению (гиперлипидемия, гипертриглицеридемия, гиперлипопротеинемия, семейная гиперхолестеринемия, болезнь Танжера и другие), режиму (тестирование по рецепту, тестирование без рецепта), бренду (Roche Reflotron, Roche Cobas B 101, Alere Cholestech LDX, Alere Afinion, Samsung Labgeo, PTS Cardiochek и другим), платформе (анализы с латеральным потоком (иммунохроматографические тесты), молекулярной диагностике, иммуноанализах, тест-полосках, микрофлюидике), конечному пользователю (больницам, профессиональным диагностическим центрам, домашнему уходу, исследовательским лабораториям, другим конечным пользователям), каналу сбыта (прямой тендер, розничные продажи), стране (ЮАР, Саудовская Аравия, ОАЭ, Египет, Израиль и остальной Ближний Восток и Африка) Отрасль Тенденции и прогноз до 2028 года

Рынок липидов POCT на Ближнем Востоке и в АфрикеАнализ рынка и аналитика: рынок липидов POCT на Ближнем Востоке и в Африке

Ожидается, что рынок липидов POCT будет расти в прогнозируемый период с 2021 по 2028 год. По данным Data Bridge Market Research, рынок будет расти со среднегодовым темпом роста 3,0% в прогнозируемый период с 2021 по 2028 год и, как ожидается, достигнет 10,05 млн долларов США к 2028 году. Рост числа хронических инфекций привел к тому, что люди стали выбирать наборы и продукты для тестирования в месте оказания помощи, и, следовательно, это будет способствовать росту рынка липидов POCT.

POCT характеризуется как тестирование, которое может быть проведено близко к пациенту, где медицинское решение может быть принято немедленно, включая результаты и мониторинг . POCT липидов также называется тестированием липидов с пациентом и позволяет врачам точно измерять результаты диагностики лабораторного качества в реальном времени менее чем за несколько минут, а не часов.

Новые биотехнологические достижения создают огромные стимулирующие факторы и стимулируют рост рынка липидных POCT. Высокая стоимость продуктов может сдерживать рост рынка липидных POCT. Ожидается, что растущие расходы на здравоохранение станут возможностью для роста рынка липидных POCT. Отсутствие согласованности с результатами тестов, полученными из лабораторий, создает огромную проблему для рынка липидных POCT.

Отчет о рынке липидных POCT содержит подробную информацию о доле рынка, новых разработках и анализе продуктового портфеля, влиянии внутренних и локальных игроков рынка, анализирует возможности с точки зрения новых источников дохода, изменений в рыночных правилах, одобрений продуктов, стратегических решений, запусков продуктов, географических расширений и технологических инноваций на рынке. Чтобы понять анализ и сценарий рынка липидных POCT, свяжитесь с Data Bridge Market Research для получения аналитического обзора, наша команда поможет вам создать решение по влиянию на доход для достижения желаемой цели.

Рынок липидов POCT на Ближнем Востоке и в АфрикеОбъем и размер рынка липидов POCT

The lipid POCT market is segmented into seven notable segments which are based on the type, application, mode, brand, platform, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of type, the lipid POCT market is segmented into instruments, consumables and kits. In 2021, the instruments segment in the lipid POCT market is expected to grow due to changing lifestyles and increasing chronic diseases and a lack of awareness of over-the-counter POCT devices.
  • On the basis of application, the lipid POCT market is segmented into hyperlipidemia, hypertriglyceridemia, hyperlipoproteinemia, tangier disease, familial hypercholesterolemia and others. In 2021, the hyperlipidemia segment in the lipid POCT market is expected to dominate because of the rising geriatric population and unhealthy lifestyle.
  • On the basis of mode, the lipid POCT market is segmented into OTC-based testing and prescription-based testing. In 2021, the prescription-based test segment in the lipid POCT market is expected to dominate because of high preference of point of care lipid testing been recommended for lipid profiling in hospitals and skilled laboratory professionals.
  • On the basis of brand, the lipid POCT market is segmented into roche reflotron, roche cobas B 101, alere cholestech LDX, alere afinion, samsung labgeo, PTS cardiochek and others. In 2021, the roche reflectron segment is expected to dominate in lipid POCT market due to their advanced technology over point of care devices.
  • On the basis of platform, the lipid POCT market is segmented into lateral flow assays (immunochromatography tests), dipsticks, microfluidics, molecular diagnostics and immunoassays. In 2021, the lateral flow assays (immunochromatography tests) segment in the lipid POCT market is expected to grow due to advanced technologies and inventions.
  • On the basis of end user, the lipid POCT market is segmented into hospitals, professional diagnostic centers, home care, research laboratories and other end users. In 2021, the hospitals segment in the lipid POCT market is expected to grow due to growing patient emphasis on diagnosis operations.
  • On the basis of distribution channel, the lipid POCT market is segmented into direct tender and retail sales. In 2021, direct tender segment in the lipid POCT market is expected to grow due to the increased demand for advanced technologies and testing requirements in medical care for operations and diagnosis.

Middle East and Africa Lipid POCT Market Country Level Analysis

Middle East and Africa lipid POCT market is analysed and market size information is provided by the country, type, application, mode, brand, platform, end user and distribution channel as referenced above.

The countries covered in the Middle East and Africa lipid POCT market report are the South Africa, Saudi Arabia, UAE, Egypt, Israel and rest of Middle East and Africa.

South Africa is going to dominate in the Middle East and Africa lipid POCT market because of the increasing diagnosis rate and awareness about the cardiovascular disease. 

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data. 

New Product Launches by Manufacturers is Creating New Opportunities for Players in the Lipid POCT Market

The lipid POCT market also provides you with detailed market analysis for every country growth in aesthetic industry with lipid POCT market sales, impact of advancement in the lipid POCT market and changes in regulatory scenarios with their support for the lipid POCT market. The data is available for historic period 2011 to 2019. 

Competitive Landscape and Lipid POCT Market Share Analysis

The lipid POCT market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Middle East and Africa lipid POCT market.

The major companies covered in the Middle East and Africa lipid POCT market report are Abbott, F. Hoffmann-La Roche Ltd., SD Biosensor, INC., PTS Diagnostics, Trinity Biotech, Siemens Healthcare GmbH (a subsidiary of Siemens), Samsung Medison Co., Ltd., Nova Biomedical, ACON Laboratories, Inc. among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launches and agreements are also initiated by the companies’ worldwide which are also accelerating the lipid POCT market.

For instance, 

  • В ноябре 2020 года SD Biosensor, INC. объявила о партнерстве с DKSH Korea с целью развития фармацевтического бизнеса по измерению уровня сахара в крови. Это поможет компании диверсифицировать свой рынок в ближайшие годы.

Сотрудничество, совместные предприятия и другие стратегии участников рынка расширяют возможности компании на рынке липидных ПОКТ, что также дает организациям возможность улучшить свое предложение на рынке липидных ПОКТ.

   

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Интерактивная панель анализа данных
  • Панель анализа компании для возможностей с высоким потенциалом роста
  • Доступ аналитика-исследователя для настройки и запросов
  • Анализ конкурентов с помощью интерактивной панели
  • Последние новости, обновления и анализ тенденций
  • Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Запросить демонстрацию

Содержание

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MIDDLE EAST AND AFRICA LIPID POCT MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7 MULTIVARIATE MODELLING

2.8 DISTRIBUTION CHANNEL LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES

5.1.2 IMPROVING DIAGNOSIS SEEKING RATE

5.1.3 RISING TECHNOLOGICAL ADVANCEMENTS

5.1.4 RISING GERIATRIC POPULATION ACROSS THE GLOBE

5.1.5 RISING PREFERENCE FOR HOMECARE TESTING

5.2 RESTRAINTS

5.2.1 PRODUCT RECALLS

5.2.2 HIGH COSTS OF PRODUCTS

5.2.3 NON-AVAILABILITY OF RELEVANT AND APPROPRIATE KITS

5.3 OPPORTUNITIES

5.3.1 STRATEGIC INITIATIVES BY THE MARKET PLAYERS

5.3.2 RISING HEALTHCARE EXPENDITURE

5.3.3 PANDEMIC OUTBREAK OF COVID-19

5.3.4 GROWING DEMAND FOR BETTER QUALITY HEALTHCARE AND EARLY DIAGNOSIS

5.4 CHALLENGES

5.4.1 LACK OF ALIGNMENT WITH TEST RESULTS OBTAINED FROM LABORATORIES

5.4.2 LACK OF ACCESSIBILITY

6 IMPACT OF COVID-19 ON THE MIDDLE EAST AND AFRICA LIPID POCT MARKET

6.1 IMPACT ON PRICE

6.2 IMPACT ON DEMAND

6.3 IMPACT ON SUPPLY CHAIN

6.4 KEY INITIATIVES BY MARKET PLAYERS DURING THE COVID 19

6.5 CONCLUSION:

1 MIDDLE EAST AND AFRICA LIPID POCT MARKET, BY TYPE

1.1 OVERVIEW

1.2 INSTRUMENTS

1.2.1 ANALYZERS

1.2.1.1 PORTABLE

1.2.1.2 HANDHELD

1.2.1.3 STANDALONE

1.2.2 METER

1.2.3 BLOOD MONITORING DEVICE

1.2.4 OTHER POC PRODUCTS

1.3 CONSUMABLES AND KITS

1.3.1 CHOLESTEROL TEST KITS

1.3.2 STRIPS

1.3.3 ACCESSORIES

1.3.4 OTHERS

2 MIDDLE EAST AND AFRICA LIPID POCT MARKET, BY APPLICATION

2.1 OVERVIEW

2.2 HYPERLIPIDEMIA

2.3 HYPERTRIGLYCERIDEMIA

2.4 HYPERLIPOPROTEINEMIA

2.5 FAMILIAL HYPERCHOLESTEROLEMIA

2.6 TANGIER DISEASE

2.7 OTHERS

3 MIDDLE EAST AND AFRICA LIPID POCT MARKET, BY MODE

3.1 OVERVIEW

3.2 PRESCRIPTION-BASED TESTING

3.3 OTC-BASED TESTING

4 MIDDLE EAST AND AFRICA LIPID POCT MARKET, BY BRAND

4.1 OVERVIEW

4.2 ROCHE REFLOTRON

4.3 ROCHE COBAS B 101

4.4 ALERE CHOLESTECH LDX

4.5 ALERE AFINION

4.6 PTS CARDIOCHEK

4.7 OTHERS

5 MIDDLE EAST AND AFRICA LIPID POCT MARKET, BY PLATFORM

5.1 OVERVIEW

5.2 LATERAL FLOW ASSAYS /IMMUNOCHROMATOGRAPHY TESTS

5.3 MOLECULAR DIAGNOSTICS

5.4 IMMUNOASSAYS

5.5 DIPSTICKS

5.6 MICROFLUIDICS

6 MIDDLE EAST AND AFRICA LIPID POCT MARKET, BY END USER

6.1 OVERVIEW

6.2 HOSPITALS

6.3 PROFESSIONAL DIAGNOSTIC CENTERS

6.3.1 CLINICAL LABORATORIES

6.3.2 OUTPATIENT HEALTHCARE & AMBULATORY CARE SETTINGS

6.4 HOME CARE

6.5 RESEARCH LABORATORIES

6.6 OTHER END USERS

7 MIDDLE EAST AND AFRICA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL

7.1 OVERVIEW

7.2 DIRECT TENDERS

7.3 RETAIL SALES

8 MIDDLE EAST AND AFRICA LIPID POCT MARKET, BY REGION

8.1 MIDDLE EAST & AFRICA

8.1.1 SOUTH AFRICA

8.1.2 SAUDI ARABIA

8.1.3 U.A.E.

8.1.4 EGYPT

8.1.5 ISRAEL

8.1.6 REST OF MIDDLE EAST & AFRICA

9 MIDDLE EAST AND AFRICA LIPID POCT MARKET: COMPANY LANDSCAPE

9.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA

10 SWOT ANALYSIS

11 COMPANY PROFILES

11.1 F. HOFFMANN-LA ROCHE LTD

11.1.1 COMPANY SNAPSHOT

11.1.2 REVENUE ANALYSIS

11.1.3 COMPANY SHARE ANALYSIS

11.1.4 PRODUCT PORTFOLIO

11.1.5 RECENT DEVELOPMENT

11.2 ABBOTT

11.2.1 COMPANY SNAPSHOT

11.2.2 REVENUE ANALYSIS

11.2.3 COMPANY SHARE ANALYSIS

11.2.4 PRODUCT PORTFOLIO

11.2.5 RECENT DEVELOPMENT

11.3 SIEMENS HEALTHCARE GMBH (A SUBSIDIARY OF SIEMENS)

11.3.1 COMPANY SNAPSHOT

11.3.2 REVENUE ANALYSIS

11.3.3 COMPANY SHARE ANALYSIS

11.3.4 PRODUCT PORTFOLIO

11.3.5 RECENT DEVELOPMENTS

11.4 QUEST DIAGNOSTICS INCORPORATED

11.4.1 COMPANY SNAPSHOT

11.4.2 REVENUE ANALYSIS

11.4.3 COMPANY SHARE ANALYSIS

11.4.4 PRODUCT PORTFOLIO

11.4.5 RECENT DEVELOPMENTS

11.5 A. MENARINI DIAGNOSTICS S.R.L

11.5.1 COMPANY SNAPSHOT

11.5.2 COMPANY SHARE ANALYSIS

11.5.3 PRODUCT PORTFOLIO

11.5.4 RECENT DEVELOPMENT

11.6 ACON LABORATORIES, INC.

11.6.1 COMPANY SNAPSHOT

11.6.2 PRODUCT PORTFOLIO

11.6.3 RECENT DEVELOPMENT

11.7 AMD SOLUTIONS

11.7.1 COMPANY SNAPSHOT

11.7.2 PRODUCT PORTFOLIO

11.7.3 RECENT DEVELOPMENTS

11.8 CALLEGARI SRL

11.8.1 COMPANY SNAPSHOT

11.8.2 PRODUCT PORTFOLIO

11.8.3 RECENT DEVELOPMENTS

11.9 EUROMEDIX

11.9.1 COMPANY SNAPSHOT

11.9.2 PRODUCT PORTFOLIO

11.9.3 RECENT DEVELOPMENT

11.1 GENERAL LIFE BIOTECHNOLOGY CO., LTD.

11.10.1 COMPANY SNAPSHOT

11.10.2 PRODUCT PORTFOLIO

11.10.3 RECENT DEVELOPMENTS

11.11 JANT PHARMACAL CORPORATION

11.11.1 COMPANY SNAPSHOT

11.11.2 PRODUCT PORTFOLIO

11.11.3 RECENT DEVELOPMENT

11.12 MICO BIOMED

11.12.1 COMPANY SNAPSHOT

11.12.2 PRODUCT PORTFOLIO

11.12.3 RECENT DEVELOPMENTS

11.13 NOVA BIOMEDICAL

11.13.1 COMPANY SNAPSHOT

11.13.2 PRODUCT PORTFOLIO

11.13.3 RECENT DEVELOPMENTS

11.14 PRIMA LAB SA

11.14.1 COMPANY SNAPSHOT

11.14.2 PRODUCT PORTFOLIO

11.14.3 RECENT DEVELOPMENTS

11.15 PTS DIAGNOSTICS

11.15.1 COMPANY SNAPSHOT

11.15.2 PRODUCT PORTFOLIO

11.15.3 RECENT DEVELOPMENTS

11.16 SD BIOSENSOR, INC.

11.16.1 COMPANY SNAPSHOT

11.16.2 PRODUCT PORTFOLIO

11.16.3 RECENT DEVELOPMENTS

11.17 SKYLA CORPORATION

11.17.1 COMPANY SNAPSHOT

11.17.2 PRODUCT PORTFOLIO

11.17.3 RECENT DEVELOPMENTS

11.18 TASCOM

11.18.1 COMPANY SNAPSHOT

11.18.2 PRODUCT PORTFOLIO

11.18.3 RECENT DEVELOPMENT

11.19 TRINITY BIOTECH

11.19.1 COMPANY SNAPSHOT

11.19.2 REVENUE ANALYSIS

11.19.3 PRODUCT PORTFOLIO

11.19.4 RECENT DEVELOPMENTS

11.2 SAMSUNG MEDISON CO., LTD.

11.20.1 COMPANY SNAPSHOT

11.20.2 PRODUCT PORTFOLIO

11.20.3 RECENT DEVELOPMENT

12 QUESTIONNAIRE

13 RELATED REPORTS

Список таблиц

LIST OF TABLES

TABLE 1 BELOW MENTIONED TABLE SHOWS THE COST OF VARIOUS LIPID POCT DEVICES OFFERED BY DIFFERENT MANUFACTURERS:

TABLE 1 MIDDLE EAST AND AFRICA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 2 MIDDLE EAST AND AFRICA INSTRUMENTS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 3 MIDDLE EAST AND AFRICA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 4 MIDDLE EAST AND AFRICA ANALYZERS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 5 MIDDLE EAST AND AFRICA CONSUMABLES & KITS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 6 MIDDLE EAST AND AFRICA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE , 2019-2028 (USD MILLION)

TABLE 7 MIDDLE EAST AND AFRICA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 8 MIDDLE EAST AND AFRICA HYPERLIPIDEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 9 MIDDLE EAST AND AFRICA HYPERTRIGLYCERIDEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 MIDDLE EAST AND AFRICA HYPERLIPOPROTEINEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 MIDDLE EAST AND AFRICA FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 MIDDLE EAST AND AFRICA TANGIER DISEASE IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 MIDDLE EAST AND AFRICA OTHERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 MIDDLE EAST AND AFRICA LIPID POCT MARKET, BY MODE, 2019 – 2028, (USD MILLION)

TABLE 15 MIDDLE EAST AND AFRICA PRESCRIPTION-BASED TESTING IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 MIDDLE EAST AND AFRICA OTC-BASED TESTING IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 MIDDLE EAST AND AFRICA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 18 MIDDLE EAST AND AFRICA ROCHE REFLOTRON IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 19 MIDDLE EAST AND AFRICA ROCHE COBAS B 101 IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 MIDDLE EAST AND AFRICA ALERE CHOLESTECH LDX IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 MIDDLE EAST AND AFRICA ALERE AFINION IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 MIDDLE EAST AND AFRICA PTS CARDIOCHEK IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 MIDDLE EAST AND AFRICA OTHERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 MIDDLE EAST AND AFRICA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 25 MIDDLE EAST AND AFRICA LATERAL FLOW ASSAYS /IMMUNOCHROMATOGRAPHY TESTS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 MIDDLE EAST AND AFRICA IMMUNOASSAYS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 MIDDLE EAST AND AFRICA DIPSTICKS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 MIDDLE EAST AND AFRICA MICROFLUIDICS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 30 MIDDLE EAST AND AFRICA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 31 MIDDLE EAST AND AFRICA HOSPITALS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 MIDDLE EAST AND AFRICA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 33 MIDDLE EAST AND AFRICA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 34 MIDDLE EAST AND AFRICA HOME CARE IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 35 MIDDLE EAST AND AFRICA RESEARCH LABORATORIES IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 36 MIDDLE EAST AND AFRICA OTHER END USERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 37 MIDDLE EAST AND AFRICA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 38 MIDDLE EAST AND AFRICA DIRECT TENDERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 39 MIDDLE EAST AND AFRICA RETAIL SALES IN LIPID POCT MARKET, BY REGION 2019-2028 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA LIPID POCT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 44 MIDDLE EAST & AFRICA ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 45 MIDDLE EAST & AFRICA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 46 MIDDLE EAST & AFRICA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 47 MIDDLE EAST & AFRICA LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 48 MIDDLE EAST & AFRICA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 49 MIDDLE EAST & AFRICA LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)

TABLE 50 MIDDLE EAST & AFRICA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 51 MIDDLE EAST & AFRICA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 52 MIDDLE EAST & AFRICA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 53 MIDDLE EAST & AFRICA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 54 SOUTH AFRICA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 55 SOUTH AFRICA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 56 SOUTH AFRICA ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 57 SOUTH AFRICA ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 58 SOUTH AFRICA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 59 SOUTH AFRICA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 60 SOUTH AFRICA LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 61 SOUTH AFRICA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 62 SOUTH AFRICA LIPID POCT MARKET, BY BRAND,2019-2028 (UNITS)

TABLE 63 SOUTH AFRICA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 64 SOUTH AFRICA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 65 SOUTH AFRICA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 66 SOUTH AFRICA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 67 SAUDI ARABIA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 68 SAUDI ARABIA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 69 SAUDI ARABIA ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 70 SAUDI ARABIA ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 71 SAUDI ARABIA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 72 SAUDI ARABIA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 73 SAUDI ARABIA LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 74 SAUDI ARABIA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 75 SAUDI ARABIA LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)

TABLE 76 SAUDI ARABIA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 77 SAUDI ARABIA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 78 SAUDI ARABIA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 79 SAUDI ARABIA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 80 U.A.E. LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 81 U.A.E. INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 82 U.A.E. ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 83 U.A.E. ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 84 U.A.E. CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 85 U.A.E. LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 86 U.A.E. LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 87 U.A.E. LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 88 U.A.E. LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)

TABLE 89 U.A.E. LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 90 U.A.E. LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 91 U.A.E. PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 92 U.A.E. LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 93 EGYPT LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 94 EGYPT INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 95 EGYPT ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 96 EGYPT ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 97 EGYPT CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 98 EGYPT LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 99 EGYPT LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 100 EGYPT LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 101 EGYPT LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)

TABLE 102 EGYPT LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 103 EGYPT LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 104 EGYPT PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 105 EGYPT LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 106 ISRAEL LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 107 ISRAEL INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 108 ISRAEL ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 109 ISRAEL ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 110 ISRAEL CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 111 ISRAEL LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 112 ISRAEL LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 113 ISRAEL LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 114 ISRAEL LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)

TABLE 115 ISRAEL LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 116 ISRAEL LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 117 ISRAEL PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 118 ISRAEL LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 119 REST OF MIDDLE EAST & AFRICA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

 

Список рисунков

LIST OF FIGURES

FIGURE 1 MIDDLE EAST AND AFRICA LIPID POCT MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST AND AFRICA LIPID POCT MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST AND AFRICA LIPID POCT MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST AND AFRICA LIPID POCT MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST AND AFRICA LIPID POCT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST AND AFRICA LIPID POCT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 MIDDLE EAST AND AFRICA LIPID POCT MARKET: MULTIVARIATE MODELLING

FIGURE 8 MIDDLE EAST AND AFRICA LIPID POCT MARKET: DBMR MARKET POSITION GRID

FIGURE 9 MIDDLE EAST AND AFRICA LIPID POCT MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 MIDDLE EAST AND AFRICA LIPID POCT MARKET: SEGMENTATION

FIGURE 11 INCREASING PREVALENCE OF CHRONIC DISEASE AND IMPROVING DIAGNOSIS SEEKING RATE ARE EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA LIPID POCT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 12 INSTRUMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA LIPID POCT MARKET IN 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST AND AFRICA LIPID POCT MARKET

FIGURE 14 TOP 10 CAUSES OF DEATHS DUE TO CHRONIC INFECTIONS IN EGYPT

FIGURE 15 MEDICAL DEVICE SPENDING VS. NATIONAL HEALTH EXPENDITURES IN 2016

FIGURE 1 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY TYPE, 2020

FIGURE 2 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY TYPE, 2019-2028 (USD MILLION)

FIGURE 3 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY TYPE, CAGR (2021-2028)

FIGURE 4 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY TYPE, LIFELINE CURVE

FIGURE 5 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY APPLICATION, 2020

FIGURE 6 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY APPLICATION, 2019-2028 (USD MILLION)

FIGURE 7 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY APPLICATION, CAGR (2021-2028)

FIGURE 8 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 9 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY MODE, 2020

FIGURE 10 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY MODE, 2019-2028 (USD MILLION)

FIGURE 11 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY MODE, CAGR (2021-2028)

FIGURE 12 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY MODE, LIFELINE CURVE

FIGURE 13 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY BRAND, 2020

FIGURE 14 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY BRAND, 2020-2028 (USD MILLION)

FIGURE 15 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY BRAND, CAGR (2021-2028)

FIGURE 16 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY BRAND, LIFELINE CURVE

FIGURE 17 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY PLATFORM, 2020

FIGURE 18 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY PLATFORM, 2019-2028 (USD MILLION)

FIGURE 19 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY PLATFORM, CAGR (2021-2028)

FIGURE 20 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY PLATFORM, LIFELINE CURVE

FIGURE 21 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY END USER, 2020

FIGURE 22 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY END USER, 2019-2028 (USD MILLION)

FIGURE 23 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY END USER, CAGR (2021-2028)

FIGURE 24 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY END USER, LIFELINE CURVE

FIGURE 25 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 26 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

FIGURE 27 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 28 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 29 MIDDLE EAST & AFRICA LIPID POCT MARKET: SNAPSHOT (2020)

FIGURE 30 MIDDLE EAST & AFRICA LIPID POCT MARKET: BY COUNTRY (2020)

FIGURE 31 MIDDLE EAST & AFRICA LIPID POCT MARKET: BY COUNTRY (2021 & 2028)

FIGURE 32 MIDDLE EAST & AFRICA LIPID POCT MARKET: BY COUNTRY (2020 & 2028)

FIGURE 33 MIDDLE EAST & AFRICA LIPID POCT MARKET: BY TYPE (2021-2028)

FIGURE 34 MIDDLE EAST AND AFRICA LIPID POCT MARKET: COMPANY SHARE 2020 (%)

 

View Detailed Information Right Arrow

Методология исследования

Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.

Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.

Доступна настройка

Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.

Просмотр связанных страниц

Banner